1. Tescalcin promotes highly invasive papillary thyroid microcarcinoma by regulating FOS/ERK signaling pathway
   Xiuhe Zou et al, 2022, BMC Cancer CrossRef
2. Comparison of droplet digital PCR and direct Sanger sequencing for the detection of the BRAFV600E mutation in papillary thyroid carcinoma
   Zhuo Wang et al, 2019, Journal of Clinical Laboratory Analysis CrossRef
3. Analytic and clinical validity of thyroid nodule mutational profiling using droplet digital polymerase chain reaction
   Vincent L. Biron et al, 2018, Journal of Otolaryngology - Head & Neck Surgery CrossRef
4. Liquid biopsy to monitor melanoma patients
   Maria Rita Gaiser et al, 2018, JDDG: Journal der Deutschen Dermatologischen Gesellschaft CrossRef
5. Association of BRAFV600E Mutation with the Aggressive Behavior of Papillary Thyroid Microcarcinoma: A Meta-Analysis of 33 Studies
   Abdallah S. Attia et al, 2022, International Journal of Molecular Sciences CrossRef
6. Research Progress of BRAF V600E Gene Mutation in Papillary Thyroid Carcinoma
   延泽 刘, 2022, Advances in Clinical Medicine CrossRef
7. Classic and Follicular Variant of Papillary Thyroid Microcarcinoma: 2 Different Phenotypes Beyond Tumor Size
   Clotilde Sparano et al, 2022, Journal of the Endocrine Society CrossRef
8. Risk and Prognostic Factors for BRAFV600E Mutations in Papillary Thyroid Carcinoma
   Xiaojing Wei et al, 2022, BioMed Research International CrossRef
9. Molecular evaluation of BRAF gene mutation in thyroid tumors: Significant association with papillary tumors and extra thyroidal extension indicating its role as a biomarker of aggressive disease
   Firoz Ahmad et al, 2018, Experimental and Molecular Pathology CrossRef
10. Liquid Biopsy zur Überwachung von Melanompatienten
    Maria Rita Gaiser et al, 2018, JDDG: Journal der Deutschen Dermatologischen Gesellschaft CrossRef